Roflo, Crestila .
HRN: 21-92-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2022
METRONIDAZOLE 500MG (TAB)
09/13/2022
09/20/2022
PO
1tab
Q8H
TMSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes